|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Deferred Stock Units | (2) | 03/15/2018 | M | 23,923 | (3) | (3) | Common Stock | 23,923 | $ 0 | 0 | D | ||||
Restricted Stock Units | (4) | 03/15/2018 | M | 11,961 | (5) | (5) | Common Stock | 11,961 | $ 0 | 0 | D | ||||
Dividend Equivalent Rights | (6) | 03/15/2018 | M | 58.1082 | (6) | (6) | Common Stock | 58.1082 | $ 0 | 101.9044 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Smith Howard W III C/O WALKER & DUNLOP, INC. 7501 WISCONSIN AVENUE, SUITE 1200E BETHESDA, MD 20814 |
X | President |
/s/ Daniel J. Groman, Attorney-in-fact | 03/19/2018 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | The Reporting Person received cash in lieu of delivery of fractional shares upon vesting of the dividend equivalent rights. |
(2) | Each deferred stock unit represents the right to receive one share of common stock of the Issuer. |
(3) | The deferred stock units are fully vested and were settled in shares of the Issuer's common stock on March 15, 2018 pursuant to the Walker & Dunlop, Inc., Management Deferred Stock Unit Purchase Plan. |
(4) | Each restricted stock unit represents the right to receive one share of common stock of the Issuer. |
(5) | The restricted stock units were settled in shares of the Issuer's common stock on March 15, 2018. |
(6) | The dividend equivalent rights accrued on restricted stock units held by the Reporting Person and will vest proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of common stock of the Issuer. |